Our Story

 

ARCE Therapeutics, Inc. was founded by Mr. Ray Chen and Dr. Chien-Tsun Kuan on Feb. 3, 2020. We are committed to revolutionizing the technology in cell therapy by harnessing patient’s own immune system to eradicate  diseases.   

ARCE is developing first-in-class and best-in-class CAR-T/CAR-NK cell therapy products for the treatment of various forms of cancers, including hematological cancers and solid tumors. ARCE provides state-of-the-art products of new generation CAR-T/CAR-NK cell therapy, to make cellular gene therapy faster, cheaper, and better and to make them affordable and accessible to patients.